Please use this identifier to cite or link to this item:
Title: SEOM clinical guidelines for the treatment of head and neck cancer (2017).
Authors: Iglesias Docampo, L C
Arrazubi Arrula, V
Baste Rotllan, N
Carral Maseda, A
Cirauqui Cirauqui, B
Escobar, Y
Lambea Sorrosal, J J
Pastor Borgoñón, M
Rueda, A
Cruz Hernández, J J
Keywords: Guidelines;HPV;Head and neck cancer;Induction chemotherapy
metadata.dc.subject.mesh: Head and Neck Neoplasms
Issue Date: 20-Nov-2017
Abstract: Head and neck cancer (HNC) is defined as malignant tumours located in the upper aerodigestive tract and represents 5% of oncologic cases in adults in Spain. More than 90% of these tumours have squamous histology. In an effort to incorporate evidence obtained since 2013 publication, Spanish Society of Medical Oncology (SEOM) presents an update of HNC diagnosis and treatment guideline. The eighth edition of TNM classification, published in January 2017, introduces important changes for p16-positive oropharyngeal tumours, for lip and oral cavity cancer and for N3 category. In addition, there are new data about induction chemotherapy and the role of immunotherapy in HNC.
metadata.dc.identifier.doi: 10.1007/s12094-017-1776-1
Appears in Collections:Producción 2020

Files in This Item:
File SizeFormat 
PMC5785598.pdf678,63 kBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons